Control of Gene Expression by Functional and Artificial Nucleic Acids
功能性和人工核酸对基因表达的控制
基本信息
- 批准号:18550151
- 负责人:
- 金额:$ 2.71万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In order to develop a novel strategy to control a gene expression, an olignnucleotidc-functional molecule conjugate has been synthesized and its biological properties were also studied. The results are summarized below.1) Some heterocyclic compounds were designed, synthesized and incorporated into a bridged nucleic acid skeleton. The obtained bridged nucleic acids bearing unnatural nucleobases were also introduced into oligonucleotides, and their triplex-forming ability was investigated. Very interestingly, it was found that the recognition of pyrimicline-purine interruption site was successfully achieved by the bridged nucleic acid derivatives /2) As a convenient method to introduce a functional group into oligonucleotides, a post-elongation modification method based on Click chemistry was developed. Furthermore, some oligonucleotides conjugated with a transcription factor-binding site (double stranded DNA) were also successfully prepared.3) The oligonucleotides bearing unnatrural nucleobases prepared above were transfected into living cells, and their ability to control gene expression was evaluated. The oligonucleotides bearing unnatural nucleobases, by themselves or together with the antigene-block strategy developed by our group, showed effective regulation of gene expression. Furthermore, the oligonucleotides conjugated with a transcription factor-binding site promoted the target gene expression. These results are of great interest and would be useful for further biological application.4) A relationship between chemical structures of oligonucleotide analogues and their triplex-forming ability was evaluated in detail, and the novel bridged nucleic acid, of which triplex-forming ability was higher than that of the pinto-type BNA, was successfully developed.
为了开发一种新的调控基因表达的策略,合成了寡核苷酸-功能分子偶联物,并对其生物学性质进行了研究。主要研究结果如下:1)设计、合成了一些杂环化合物,并将其引入到桥联核酸骨架中。将所获得的带有非天然核碱基的桥接核酸也引入寡核苷酸中,并研究它们的三链体形成能力。非常有趣的是,发现通过桥接的核酸衍生物成功地实现了嘧啶霉素-嘌呤中断位点的识别/2)作为将官能团引入寡核苷酸的方便方法,开发了基于点击化学的延伸后修饰方法。3)将上述制备的含有非天然碱基的寡核苷酸转染到活细胞中,观察其调控基因表达的能力。带有非天然核碱基的寡核苷酸,单独或与我们小组开发的抗原阻断策略一起,显示出对基因表达的有效调节。此外,与转录因子结合位点缀合的寡核苷酸促进靶基因的表达。这些结果对进一步的生物学应用具有重要意义。4)详细研究了寡核苷酸类似物的化学结构与其三链体形成能力之间的关系,并成功构建了三链体形成能力高于pinto型BNA的新型桥联核酸。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Design, Synthesis and Evaluation of a Novel Bridged Nucleic Acid, 2',5'-BNA^<ON> with S-type Sugar Conformation Fixed by an N-O Linkage
具有通过 N-O 连接固定的 S 型糖构象的新型桥接核酸 2,5-BNA^<ON> 的设计、合成和评估
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:T. Kodama;C. Matsuo;H. Ori;T. Miyoshi;S. Obika;K. Miyashita;T. Imanishi
- 通讯作者:T. Imanishi
Synthesis and Properties of Bridged Nucleic Acids
桥联核酸的合成与性质
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:S. Obika;T. Imanishi
- 通讯作者:T. Imanishi
Recognition of T-A Interruption by 2', 4'-BNAs Bearing Heteroaromatic Nucleobases Through Parallel Motif Triplex Formation
2, 4-BNA 通过平行基序三链体形成来识别 T-A 中断
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:S. Obika;et al.
- 通讯作者:et al.
Biologically active 2-5A analogs containing 3'-O, 4'-C-propylene adenosine as potent RNase L agonists
含有 3-O, 4-C-丙烯腺苷的生物活性 2-5A 类似物,作为有效的 RNase L 激动剂
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:K. Morita;et al.
- 通讯作者:et al.
Recognition of T・A Interruption by 2', 4'-BNAs Bearing Heteroaxomatic Nucleobases Through Parallel Motif Triplex Formation
通过平行基序三链体形成携带异核碱基的 2, 4-BNA 识别 T·A 中断
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:S. Obika;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OBIKA Satoshi其他文献
OBIKA Satoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OBIKA Satoshi', 18)}}的其他基金
The identification of long-noncoding RNAs associated with the formation of atherosclerotic plaques and their therapeutic manipulation strategy
与动脉粥样硬化斑块形成相关的长链非编码RNA的鉴定及其治疗操作策略
- 批准号:
25670028 - 财政年份:2013
- 资助金额:
$ 2.71万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulation of RNA Splicing by BNA Antisense Oligonucleotides
BNA 反义寡核苷酸对 RNA 剪接的调控
- 批准号:
23651236 - 财政年份:2011
- 资助金额:
$ 2.71万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of oligonucleotide-based artificial transcription factor based on the higher-order structure of nucleic acids
基于核酸高阶结构的寡核苷酸人工转录因子的开发
- 批准号:
21350094 - 财政年份:2009
- 资助金额:
$ 2.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
IMPROVED ANTISENSE OLIGONUCLEOIDES, & THEIR SCALE UP
改进的反义寡核苷酸,
- 批准号:
3493052 - 财政年份:1992
- 资助金额:
$ 2.71万 - 项目类别:














{{item.name}}会员




